News of Note—Emergent BioSolutions and GeoVax

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Emergent BioSolutions filed for an FDA emergency use authorization for its anthrax vaccine NuThrax. Release

> GeoVax teamed up with Enesi Pharma to develop vaccines on a needle-free delivery platform. Release

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.